Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27081
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBalasubramanian, Adithya-
dc.contributor.authorQu, Liang G-
dc.contributor.authorWeickhardt, Andrew J-
dc.contributor.authorBolton, Damien M-
dc.contributor.authorPerera, Marlon-
dc.date.accessioned2021-07-26T05:07:03Z-
dc.date.available2021-07-26T05:07:03Z-
dc.date.issued2021-07-
dc.identifier.citationInternal Medicine Journal 2021; 51(7): 1173-1177en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27081-
dc.description.abstractThe availability of efficacious systemic therapies for metastatic clear cell renal cell carcinoma has heralded improved survival for Australians. The Pharmaceutical Benefits Schedule registry was interrogated to assess nation-wide prescribing patterns. Sunitinib remained the most commonly prescribed agent. Prescribing rates were significantly lower in Northern Territory than in other states, raising questions of disparities in access to care.en
dc.language.isoeng
dc.subjectimmunotherapyen
dc.subjectmetastaticen
dc.subjectoncologyen
dc.subjectrenal cell canceren
dc.subjectsystemic therapiesen
dc.subjecttyrosine kinase inhibitorsen
dc.titleChanges in prescribing habits for the treatment of metastatic renal clear cell carcinoma (mRCC) in Australia.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternal Medicine Journalen
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen
dc.identifier.affiliationDepartment of Medical Oncology, Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationDepartment of Urology, Western Health, University of Melbourne, Victoria, Australiaen
dc.identifier.affiliationAustin Healthen
dc.identifier.doi10.1111/imj.15419en
dc.type.contentTexten
dc.identifier.orcid0000-0002-1138-6389en
dc.identifier.pubmedid34278692
local.name.researcherBalasubramanian, Adithya
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMedical Oncology-
crisitem.author.deptUrology-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptUrology-
crisitem.author.deptSurgery-
crisitem.author.deptUrology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Nov 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.